ArticleJournal of medicinal chemistry2026

The Discovery of GSK3227634: A Potent Inhaled Inhibitor of the KEAP1/NRF2 Protein-Protein Interaction for the Treatment of Chronic Obstructive Pulmonary Disease.

James F Callahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.